Literature DB >> 32338819

Management of pleomorphic dermal sarcoma.

Sarah Lonie1, Benny Yau1, Michael Henderson1,2, David Gyorki1,2, Christopher Angel3, Angela Webb1,2.   

Abstract

BACKGROUND: Pleomorphic dermal sarcoma (PDS) is a rare, poorly defined skin neoplasm with features similar to atypical fibroxanthoma, but with adverse histopathological characteristics indicating metastatic potential such as tumour necrosis, invasion beyond superficial subcutis or vascular and/or perineural infiltration. Optimal treatment for PDS is uncertain and reported outcomes vary due to the rarity of this diagnosis and uncertainty over histopathological categorization. The aim of this study was to review the clinical and histopathological features of PDS in a single Australian centre.
METHODS: A retrospective review of all patients managed at the Peter MacCallum Cancer Centre with PDS between 2003 and 2017 was performed by a search of electronic records and histories reviewed.
RESULTS: A total of 27 patients were identified, mostly elderly males (85.2%, mean age 79.8 years). Lesions were seen most commonly on the head and neck region (96.3%), predominantly on the scalp (63%). Mean tumour radial surgical excision margin was 12.8 mm. Eighteen patients (66.7%) underwent radiotherapy; 13 adjuvant, three neoadjuvant and two with palliative intent. After median follow-up of 46.4 months, two patients had recurrence (7.4%); both had inadequate deep margins at first excision. There were three all-cause deaths in the cohort. There was one disease-specific mortality with metastatic PDS disease at the time of initial presentation.
CONCLUSION: PDS is a rare cutaneous malignancy most commonly found in the head and neck region in elderly men, which is best managed with adequate surgical excision. The role of radiotherapy is undefined and an area for future investigation.
© 2020 Royal Australasian College of Surgeons.

Entities:  

Keywords:  sarcoma; skin neoplasm; skin surgery; surgical oncology; treatment

Mesh:

Year:  2020        PMID: 32338819     DOI: 10.1111/ans.15909

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  3 in total

1.  Pleomorphic dermal sarcoma of the scalp: Review of management and distinguishing features from atypical fibroxanthoma.

Authors:  Alexa J Cohen; Sahithi Talasila; Bojan Lazarevic; Laura Gleason; Viral Patel; Neda Nikbakht
Journal:  JAAD Case Rep       Date:  2022-09-13

2.  Oncological Safety and Recurrence in the Surgical Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma of the Scalp.

Authors:  Johannes Zeller; Jurij Kiefer; David Braig; Oscar Winninger; Daniel Kraus; Salome Hagelstein; Steffen U Eisenhardt
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

3.  Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden.

Authors:  Melike Ak; Abdullah Kahraman; Fabian M Arnold; Patrick Turko; Mitchell P Levesque; Martin Zoche; Egle Ramelyte; Reinhard Dummer
Journal:  Genes (Basel)       Date:  2021-06-25       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.